Catalyst: A Biopharmaceutical Company Focused on Rare Diseases

Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.

Patient registries: A catalyst for developing new therapies for

Blog PhRMA

Jaymie Rodems on LinkedIn: Catalyst Pharmaceuticals to License

Catalyst Pharmaceuticals, Inc. on LinkedIn: Catalyst

Catalyst Pharmaceuticals, Inc. on LinkedIn: Four key strategies

If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago

The Next Wave of Biotechnology - by Vibe Bio and Ray Dogum

Top 32 Similar websites like fdatracker.com and alternatives

Catalyst: A Biopharmaceutical Company Focused on Rare Diseases

Knowledge-based approaches to drug discovery for rare diseases

Catalyst Pharmaceuticals, Inc. on LinkedIn: Four key strategies

Catalyst Pharmaceuticals, Inc.

Catalyst (@CatalystForRare) / X

AllStripes Secures $50M to Advance Global Rare Disease Research